Fidelity Investments’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.62M Buy
396,233
+29,547
+8% +$248K ﹤0.01% 2422
2025
Q4
$2.73M Buy
366,686
+74,152
+25% +$533K ﹤0.01% 2497
2025
Q3
$1.96M Sell
292,534
-9,062
-3% -$62.9K ﹤0.01% 2551
2025
Q2
$2M Sell
301,596
-696,753
-70% -$4.94M ﹤0.01% 2486
2025
Q1
$9.13M Buy
998,349
+29,399
+3% +$294K ﹤0.01% 1956
2024
Q4
$10.2M Buy
968,950
+802,155
+481% +$9.49M ﹤0.01% 1931
2024
Q3
$1.99M Buy
166,795
+166,014
+21,257% +$1.44M ﹤0.01% 2401
2024
Q2
$4.49K Sell
781
-171
-18% -$938 ﹤0.01% 4572
2024
Q1
$4.95K Sell
952
-1,186
-55% -$5.8K ﹤0.01% 4510
2023
Q4
$11.3K Buy
2,138
+1,165
+120% +$4.61K ﹤0.01% 4204
2023
Q3
$3.21K Buy
973
+17
+2% +$60 ﹤0.01% 4433
2023
Q2
$2.76K Sell
956
-8,043
-89% -$15.4K ﹤0.01% 4515
2023
Q1
$9.63K Buy
8,999
+4,936
+121% +$9.44K ﹤0.01% 4142
2022
Q4
$10.6K Buy
4,063
+2,783
+217% +$12.2K ﹤0.01% 3988
2022
Q3
$9K Buy
1,280
+712
+125% +$5.58K ﹤0.01% 4113
2022
Q2
$4K Buy
568
+26
+5% +$265 ﹤0.01% 4359
2022
Q1
$8K Buy
+542
New +$7.25K ﹤0.01% 4290

Other funds holding BVS